Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Medical Legal
US Supreme Court to Review Data Mining Laws
As we noted last year, the United States Court of Appeals for the First Circuit concluded that a Vermont law, which banned data…
Affordable Care Act Individual Mandate Struck Down by US District Court
Contained within the Affordable Care Act (ACA) was Section 1501, known as the Minimum Essential Coverage Provision (the…
NY Times: Antipsychotics and the Legal Industries Side Effects
There are risks and benefits to everything in life, and the drugs that pharmaceutical companies make are no exception. The Food…
The Ghosts behind the Ghosts: Trial Attorneys and the Ghost Writing…
Transparency and disclosure are the key elements necessary to ensure that the public and other clinicians can fairly evaluate the…
Novartis Trileptal $422.5 Million Settlement and Corporate Integrity…
The Department of Justice (DOJ) announced that Novartis Pharmaceuticals Corporation has agreed to pay $422.5 million to resolve…
Forest Laboratories Settlement and Corporate Integrity Agreement
The Department of Justice (DOJ) announced that drug maker Forest Laboratories, Inc. has pleading guilty to resolve criminal…
Allergan Botox Settlement and Corporate Integrity Agreement
This week, the United States Department of Justice (DOJ) announced that it has reached a resolution regarding the previously…
JAMA: Industry-Free Continuing Medical Education is Not Without Challenges
With a growing number of medical institutions and organizations responding to concerns about potential biases in industry funded…
Pharmaceutical Marketing Lawsuits Slowing Considerably
According to the Rx Compliance Report, “federal prosecutors are reporting that the pace of new qui tam filings (whistle blower…
Ortho-McNeil Settlement and Corporate Integrity Agreement
Last week was not the only settlement agreement (AstraZeneca) signed between a pharmaceutical company and the Office of…